Coldstream Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $291K | Buy |
|
|||||
|
2025
Q1 | $258K | Buy |
|
|||||
|
2024
Q4 | $253K | Sell |
|
|||||
|
2024
Q3 | $356K | Sell |
|
|||||
|
2024
Q2 | $391K | Sell |
|
|||||
|
2024
Q1 | $514K | Buy |
|
|||||
|
2023
Q4 | $418K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $229K | Sell |
|
|||||
|
2023
Q1 | $242K | Sell |
|
|||||
|
2022
Q4 | $340K | Buy |
|
|||||
|
2022
Q2 | $233K | Buy |
|
|||||
|
2022
Q1 | $293K | Sell |
|
|||||
|
2021
Q4 | $391K | Sell |
|
|||||
|
2021
Q3 | $244K | Sell |
|
|||||
|
2021
Q2 | $417K | Buy |
|
|||||
|
2021
Q1 | $312K | Buy |
|
|||||
|
2020
Q4 | $266K | Buy |
|
|||||
|
2020
Q3 | $238K | Buy |
|